Topical Delivery of Tofacitinib in Dermatology: The Promise of a Novel Therapeutic Class Using Biodegradable Dendritic Polyglycerol Sulfates

MLA

Fatemeh Zabihi, et al. “Topical Delivery of Tofacitinib in Dermatology: The Promise of a Novel Therapeutic Class Using Biodegradable Dendritic Polyglycerol Sulfates.” Pharmaceuticals, vol. 17, no. 1, Jan. 2024, p. 77. EBSCOhost, https://doi.org/10.3390/ph17010077.

APA

Fatemeh Zabihi, Mariam Cherri, Xiao Guo, Fiorenza Rancan, Fabian Schumacher, Ehsan Mohammadifar, Burkhard Kleuser, Wolfgang Bäumer, Michael Schirner, Annika Vogt, & Rainer Haag. (2024). Topical Delivery of Tofacitinib in Dermatology: The Promise of a Novel Therapeutic Class Using Biodegradable Dendritic Polyglycerol Sulfates. Pharmaceuticals, 17(1), 77. https://doi.org/10.3390/ph17010077

Chicago

Fatemeh Zabihi, Mariam Cherri, Xiao Guo, Fiorenza Rancan, Fabian Schumacher, Ehsan Mohammadifar, Burkhard Kleuser, et al. 2024. “Topical Delivery of Tofacitinib in Dermatology: The Promise of a Novel Therapeutic Class Using Biodegradable Dendritic Polyglycerol Sulfates.” Pharmaceuticals 17 (1): 77. doi:10.3390/ph17010077.